Breast cancer antigen 225/BCA-225

Cu-18, Ms, 6 ml RTU

Technische Daten
Reaktivität AK:Human, others not tested.
Format AK:Ready-to-use
Ig Unterklasse:IgG1
Immunogen:Breast carcinoma associated glycoprotein BCA-225
Anwendung AK:IHC(p),IHC(f)
Fixierung:1) NOTOXhisto 2) Formalin
Zelluläre Lokalisation:Cytoplasmic
Kontrolle:Breast carcinoma, fallopian tube, kidney, skin (sweat glands)
Lagerung AK:Store at 2 - 8 °C. Do not use after expiration date indicated on the vial.
Verfügbar in folgenden Ländern:world wide

This antibody recognizes a 220 - 225 kD glycoprotein of human breast carcinoma, different in size and distribution from other breast carcinoma antigens. It stains adenocarcinomas of lung, endometrium and ovary. It is non-reactive with tissues of parotid, thyroid, pancreas, liver, prostate, colon and stomach.


[1] Kummar S, Fogarasi M, Canova A et al. (2002): Cytokeratin 7 and 20 staining for the diagnosis of lung and colorectal adenocarcinoma. Br J Cancer. 86(12):1884-7.
[2] Chu P, Wu E and Weiss LM (2000): Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol. 13(9):962-72.